MedPath

Actigraphic Measurement of a Neurosurgical Procedure

Not Applicable
Completed
Conditions
Sleep Disorders
Circadian Rhythm
Pain
Rehabilitation
Mood Lability
Registration Number
NCT00945230
Lead Sponsor
Child Psychopharmacology Institute
Brief Summary

The study examines and illustrates the utility of utilizing actigraphic measurements to assess treatment response.

Detailed Description

Actigraphic measurements, repeated verbal fluency and multi-symptom operationally defined observations will be recorded for an 11 to 12 day baseline period and continued following neurosurgical tumor resection until a repeat MRI is completed three months after the procedure.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
1
Inclusion Criteria
  • Diagnosis of incidental meningioma
  • Single subject preparing to receive neurosurgical intervention
Exclusion Criteria
  • Inability to wear actigraphy device

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Pre and Post Actigraphic and Systematic Observation Scale measurementsMarch 15, 2009-June 20, 2009
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Child Psychopharmacology Institute

🇺🇸

Fargo, North Dakota, United States

Child Psychopharmacology Institute
🇺🇸Fargo, North Dakota, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.